3WA5
 
 | | Crystal Structure of type VI peptidoglycan muramidase effector Tse3 in complex with its cognate immunity protein Tsi3 | | 分子名称: | 1,2-ETHANEDIOL, CALCIUM ION, Tse3-specific immunity protein, ... | | 著者 | Ding, J, Wang, T, Liu, W, Wang, D.C. | | 登録日 | 2013-04-26 | | 公開日 | 2013-10-02 | | 最終更新日 | 2019-12-25 | | 実験手法 | X-RAY DIFFRACTION (1.9 Å) | | 主引用文献 | Complex structure of type VI peptidoglycan muramidase effector and a cognate immunity protein.
Acta Crystallogr.,Sect.D, 69, 2013
|
|
5Z2C
 | | Crystal structure of ALPK-1 N-terminal domain in complex with ADP-heptose | | 分子名称: | Alpha-protein kinase 1, [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] [(2S,3S,4S,5S,6R)-6-[(1S)-1,2-bis(oxidanyl)ethyl]-3,4,5-tris(oxidanyl)oxan-2-yl] hydrogen phosphate | | 著者 | Ding, J, She, Y, Shao, F. | | 登録日 | 2018-01-02 | | 公開日 | 2018-08-22 | | 最終更新日 | 2024-03-27 | | 実験手法 | X-RAY DIFFRACTION (2.594 Å) | | 主引用文献 | Alpha-kinase 1 is a cytosolic innate immune receptor for bacterial ADP-heptose.
Nature, 561, 2018
|
|
3AJM
 | | Crystal structure of programmed cell death 10 in complex with inositol 1,3,4,5-tetrakisphosphate | | 分子名称: | INOSITOL-(1,3,4,5)-TETRAKISPHOSPHATE, Programmed cell death protein 10 | | 著者 | Ding, J, Wang, D.C. | | 登録日 | 2010-06-09 | | 公開日 | 2010-06-30 | | 最終更新日 | 2024-03-13 | | 実験手法 | X-RAY DIFFRACTION (2.3 Å) | | 主引用文献 | Crystal structure of human programmed cell death 10 complexed with inositol-(1,3,4,5)-tetrakisphosphate: a novel adaptor protein involved in human cerebral cavernous malformation.
Biochem.Biophys.Res.Commun., 399, 2010
|
|
4YKC
 | |
1AVP
 | |
4YL6
 | |
4YKD
 | |
3WLC
 | | Crystal structure of dimeric GCaMP6m | | 分子名称: | CALCIUM ION, Myosin light chain kinase, Green fluorescent protein, ... | | 著者 | Ding, J, Luo, A.F, Hu, L.Y, Wang, D.C, Shao, F. | | 登録日 | 2013-11-08 | | 公開日 | 2014-01-22 | | 最終更新日 | 2023-12-06 | | 実験手法 | X-RAY DIFFRACTION (2.49 Å) | | 主引用文献 | Structural basis of the ultrasensitive calcium indicator GCaMP6.
Sci China Life Sci, 57, 2014
|
|
3WLD
 | | Crystal structure of monomeric GCaMP6m | | 分子名称: | CALCIUM ION, Myosin light chain kinase, Green fluorescent protein, ... | | 著者 | Ding, J, Luo, A.F, Hu, L.Y, Wang, D.C, Shao, F. | | 登録日 | 2013-11-08 | | 公開日 | 2014-01-22 | | 最終更新日 | 2023-12-06 | | 実験手法 | X-RAY DIFFRACTION (2.7 Å) | | 主引用文献 | Structural basis of the ultrasensitive calcium indicator GCaMP6.
Sci China Life Sci, 57, 2014
|
|
5B5R
 | | Crystal structure of GSDMA3 | | 分子名称: | Gasdermin-A3 | | 著者 | Ding, J, Shao, F. | | 登録日 | 2016-05-14 | | 公開日 | 2016-06-15 | | 最終更新日 | 2017-09-27 | | 実験手法 | X-RAY DIFFRACTION (1.902 Å) | | 主引用文献 | Pore-forming activity and structural autoinhibition of the gasdermin family.
Nature, 535, 2016
|
|
6ACI
 | |
6AC0
 | |
6KMV
 | |
6KMZ
 | |
6KMU
 | |
7DN8
 | |
7DN9
 | |
6KN1
 | |
6KN0
 | |
6KMT
 | | P32 of caspase-11 mutant C254A | | 分子名称: | Caspase-4 | | 著者 | Ding, J, Sun, Q. | | 登録日 | 2019-08-01 | | 公開日 | 2020-03-11 | | 最終更新日 | 2023-11-22 | | 実験手法 | X-RAY DIFFRACTION (2.6 Å) | | 主引用文献 | Structural Mechanism for GSDMD Targeting by Autoprocessed Caspases in Pyroptosis.
Cell, 180, 2020
|
|
7WZS
 | |
1WAV
 | | CRYSTAL STRUCTURE OF FORM B MONOCLINIC CRYSTAL OF INSULIN | | 分子名称: | INSULIN, PHENOL, ZINC ION | | 著者 | Liang, D.-C, Ding, J.-H, Chang, W.-R, Wan, Z.-L. | | 登録日 | 1996-02-28 | | 公開日 | 1997-02-28 | | 最終更新日 | 2024-06-05 | | 実験手法 | X-RAY DIFFRACTION (2.5 Å) | | 主引用文献 | Molecular replacement study on form-B monoclinic crystal of insulin.
Sci.China, Ser.C: Life Sci., 39, 1996
|
|
8HQN
 | | Activation mechanism of GPR132 by 9(S)-HODE | | 分子名称: | (9S,10E,12Z)-9-hydroxyoctadeca-10,12-dienoic acid, Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2, Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1, ... | | 著者 | Wang, J.L, Ding, J.H, Sun, J.P, Yu, X. | | 登録日 | 2022-12-13 | | 公開日 | 2023-10-11 | | 最終更新日 | 2023-11-01 | | 実験手法 | ELECTRON MICROSCOPY (3 Å) | | 主引用文献 | Functional screening and rational design of compounds targeting GPR132 to treat diabetes.
Nat Metab, 5, 2023
|
|
8HVI
 | | Activation mechanism of GPR132 by compound NOX-6-7 | | 分子名称: | 3-methyl-5-[(4-oxidanylidene-4-phenyl-butanoyl)amino]-1-benzofuran-2-carboxylic acid, Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2, Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1, ... | | 著者 | Wang, J.L, Ding, J.H, Sun, J.P, Yu, X. | | 登録日 | 2022-12-26 | | 公開日 | 2023-10-11 | | 最終更新日 | 2023-11-01 | | 実験手法 | ELECTRON MICROSCOPY (3.04 Å) | | 主引用文献 | Functional screening and rational design of compounds targeting GPR132 to treat diabetes.
Nat Metab, 5, 2023
|
|
8HQM
 | | Activation mechanism of GPR132 by NPGLY | | 分子名称: | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2, Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1, Guanine nucleotide-binding protein G(i) subunit alpha-1, ... | | 著者 | Wang, J.L, Ding, J.H, Sun, J.P, Yu, X. | | 登録日 | 2022-12-13 | | 公開日 | 2023-10-11 | | 最終更新日 | 2023-11-01 | | 実験手法 | ELECTRON MICROSCOPY (2.95 Å) | | 主引用文献 | Functional screening and rational design of compounds targeting GPR132 to treat diabetes.
Nat Metab, 5, 2023
|
|
